Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul 1;202(1):16-20.
doi: 10.1164/rccm.202005-1906ED.

Home Nitric Oxide Therapy for COVID-19

Roger A Alvarez  1 , Lorenzo Berra  2 , Mark T Gladwin  3   4
Affiliations
Editorial

Home Nitric Oxide Therapy for COVID-19

Roger A Alvarez et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Summary of major therapeutic properties of inhaled nitric oxide gas (NO). From top left: inhaled NO gas is known to be a selective pulmonary vasodilator. NO can improve right heart function and decrease pulmonary vasoconstriction in subjects with acute and chronic pulmonary hypertension. Middle left vignette: breathing NO gas is shown to improve ventilation and provide bronchodilation in mild asthmatic subjects. Bottom left vignette: NO gas in the alveolar space improves oxygenation by increasing blood flow to ventilated lung units (i.e., improvement of ventilation perfusion matching). Top and middle right vignettes: in vitro and in vivo data showed that NO gas can act as an antiinflammatory and antithrombotic agent. Bottom right vignette: NO donors and NO gas showed antibacterial and antiviral properties in in vitro studies and early clinical investigations. The extent of benefits of these six therapeutic pathways of NO gas in coronavirus disease (COVID-19) infection are now under investigation. Some of those studies testing NO therapeutic properties are highlighted in Table 1.
See this image and copyright information in PMC

Comment on

References

    1. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382:e60. - PMC - PubMed
    1. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. [online ahead of print] 19 Mar 2020; DOI: 10.1007/s00330-020-06801-0. - PMC - PubMed
    1. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418. - PMC - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. [online ahead of print] 22 Apr 2020; DOI: 10.1001/jama.2020.6775. - PMC - PubMed
    1. Zamanian RT, Pollack CV, Jr., Gentile MA, Rashid M, Fox JC, Mahaffey KW, et al. Outpatient inhaled nitric oxide in a patient with vasoreactive idiopathic pulmonary arterial hypertension and COVID-19 infection [letter] Am J Respir Crit Care Med. 2020;202:130–132. - PMC - PubMed